At&T (T) Stock Declined While Wilkins Investment Counsel Trimmed by $561,444 Its Stake; Neumeier Poma Investment Counsel Has Lowered Stake in Supernus Pharmaceuticals (SUPN) by $6.77 Million

February 24, 2018 - By Nellie Frank

Wilkins Investment Counsel Inc decreased its stake in At&T (T) by 11.47% based on its latest 2017Q3 regulatory filing with the SEC. Wilkins Investment Counsel Inc sold 14,396 shares as the company’s stock declined 7.81% while stock markets rallied. The institutional investor held 111,149 shares of the telecommunications equipment company at the end of 2017Q3, valued at $4.35 million, down from 125,545 at the end of the previous reported quarter. Wilkins Investment Counsel Inc who had been investing in At&T for a number of months, seems to be less bullish one the $225.42 billion market cap company. The stock increased 0.69% or $0.25 during the last trading session, reaching $36.72. About 17.45 million shares traded. AT&T Inc. (NYSE:T) has declined 0.52% since February 24, 2017 and is downtrending. It has underperformed by 17.22% the S&P500.

Neumeier Poma Investment Counsel Llc decreased its stake in Supernus Pharmaceuticals Inc. (SUPN) by 19.01% based on its latest 2017Q3 regulatory filing with the SEC. Neumeier Poma Investment Counsel Llc sold 169,320 shares as the company’s stock rose 29.12% with the market. The institutional investor held 721,420 shares of the health care company at the end of 2017Q3, valued at $28.86 million, down from 890,740 at the end of the previous reported quarter. Neumeier Poma Investment Counsel Llc who had been investing in Supernus Pharmaceuticals Inc. for a number of months, seems to be less bullish one the $2.02 billion market cap company. The stock increased 2.47% or $0.95 during the last trading session, reaching $39.4. About 291,143 shares traded. Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) has risen 91.80% since February 24, 2017 and is uptrending. It has outperformed by 75.10% the S&P500.

Among 11 analysts covering Supernus Pharmaceuticals (NASDAQ:SUPN), 8 have Buy rating, 0 Sell and 3 Hold. Therefore 73% are positive. Supernus Pharmaceuticals had 36 analyst reports since August 26, 2015 according to SRatingsIntel. Zacks downgraded the shares of SUPN in report on Wednesday, August 26 to “Hold” rating. The firm has “Buy” rating given on Monday, October 23 by Cowen & Co. The firm has “Buy” rating given on Monday, November 6 by Cantor Fitzgerald. The stock has “Buy” rating by Jefferies on Thursday, August 3. On Monday, July 17 the stock rating was maintained by Stifel Nicolaus with “Buy”. The firm earned “Market Perform” rating on Monday, July 18 by Northland Capital. The company was maintained on Thursday, August 3 by Cowen & Co. The rating was upgraded by Stifel Nicolaus on Wednesday, November 8 to “Buy”. Cantor Fitzgerald maintained the shares of SUPN in report on Monday, September 18 with “Buy” rating. The firm has “Outperform” rating given on Thursday, November 5 by Northland Capital.

Analysts await Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) to report earnings on February, 27 after the close. They expect $0.26 earnings per share, 0.00% or $0.00 from last year’s $0.26 per share. SUPN’s profit will be $13.33 million for 37.88 P/E if the $0.26 EPS becomes a reality. After $0.29 actual earnings per share reported by Supernus Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -10.34% negative EPS growth.

Investors sentiment decreased to 0.98 in 2017 Q3. Its down 0.34, from 1.32 in 2017Q2. It worsened, as 22 investors sold SUPN shares while 97 reduced holdings. 42 funds opened positions while 75 raised stakes. 48.75 million shares or 3.64% more from 47.04 million shares in 2017Q2 were reported. Reilly Fincl Advisors Ltd Liability holds 0.01% of its portfolio in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) for 2,000 shares. Smith Asset Lp accumulated 61,367 shares. Proshare Advisors Limited Company owns 32,802 shares for 0.01% of their portfolio. Ranger Invest Mgmt LP has 988,840 shares. 140,095 are held by Citigroup Incorporated. Pitcairn Communications accumulated 0.04% or 8,197 shares. Teachers Retirement Of The State Of Kentucky reported 0.01% in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). California State Teachers Retirement System stated it has 0.01% of its portfolio in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). Amalgamated Retail Bank invested in 0.01% or 6,539 shares. Piermont Cap Management, a Missouri-based fund reported 10,290 shares. Credit Suisse Ag holds 72,719 shares. Alps Advisors accumulated 61,275 shares or 0.02% of the stock. Moreover, Eam Investors Limited Liability Co has 0.31% invested in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). Glenmede Trust Na owns 0.13% invested in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) for 721,097 shares. Legal & General Grp Public Ltd has invested 0% of its portfolio in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN).

Since September 7, 2017, it had 0 insider buys, and 10 insider sales for $15.31 million activity. $630,650 worth of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) shares were sold by Vaughn Victor. On Friday, September 8 the insider Bhatt Padmanabh P. sold $249,303. Schwabe Stefan K.F. also sold $4.43M worth of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) on Thursday, September 7.

Neumeier Poma Investment Counsel Llc, which manages about $475.08M and $956.70M US Long portfolio, upped its stake in Wns Holdings Ltd. (NYSE:WNS) by 64,225 shares to 1.18M shares, valued at $42.97 million in 2017Q3, according to the filing. It also increased its holding in First Financial Bancorp (NASDAQ:FFBC) by 57,800 shares in the quarter, for a total of 996,955 shares, and has risen its stake in Ipg Photonics Corp. (NASDAQ:IPGP).

Analysts await AT&T Inc. (NYSE:T) to report earnings on April, 24. They expect $0.85 earnings per share, up 14.86% or $0.11 from last year’s $0.74 per share. T’s profit will be $5.22 billion for 10.80 P/E if the $0.85 EPS becomes a reality. After $0.78 actual earnings per share reported by AT&T Inc. for the previous quarter, Wall Street now forecasts 8.97% EPS growth.

Investors sentiment increased to 1.17 in 2017 Q3. Its up 0.02, from 1.15 in 2017Q2. It increased, as 77 investors sold T shares while 609 reduced holdings. 106 funds opened positions while 696 raised stakes. 3.34 billion shares or 1.04% more from 3.31 billion shares in 2017Q2 were reported. Illinois-based North Star Invest Corporation has invested 0.86% in AT&T Inc. (NYSE:T). Cadinha And Co Ltd Co holds 0.1% of its portfolio in AT&T Inc. (NYSE:T) for 14,874 shares. Hartford Fincl Management Inc has 50,079 shares. Crestpoint Cap Mngmt Ltd Liability Corporation accumulated 1.14% or 65,200 shares. Vident Advisory Llc invested in 0.09% or 41,909 shares. Cypress Cap Mgmt Limited Liability Co owns 340,696 shares. Gotham Asset Ltd Liability Com holds 0.41% of its portfolio in AT&T Inc. (NYSE:T) for 721,269 shares. Sigma Planning reported 259,908 shares. 193,149 were reported by First Bancorp. Insight 2811 stated it has 21,911 shares or 0.63% of all its holdings. North American Mngmt Corp holds 1.18% of its portfolio in AT&T Inc. (NYSE:T) for 191,208 shares. Financial Bank Of Nova Scotia accumulated 1.62M shares. State Of Alaska Department Of Revenue has invested 0.39% in AT&T Inc. (NYSE:T). Carnegie Cap Asset Ltd owns 257,730 shares for 1.06% of their portfolio. Becker Capital invested in 1.17M shares or 1.58% of the stock.

Among 30 analysts covering AT&T Inc. (NYSE:T), 10 have Buy rating, 1 Sell and 19 Hold. Therefore 33% are positive. AT&T Inc. had 73 analyst reports since July 27, 2015 according to SRatingsIntel. Barclays Capital maintained AT&T Inc. (NYSE:T) rating on Friday, July 15. Barclays Capital has “Overweight” rating and $45 target. Argus Research maintained the stock with “Buy” rating in Tuesday, April 11 report. On Friday, April 1 the stock rating was downgraded by Moffet Nathanson to “Sell”. Deutsche Bank maintained AT&T Inc. (NYSE:T) on Monday, November 14 with “Buy” rating. Citigroup maintained AT&T Inc. (NYSE:T) rating on Tuesday, July 19. Citigroup has “Buy” rating and $48 target. The stock of AT&T Inc. (NYSE:T) has “Mkt Perform” rating given on Thursday, January 26 by FBR Capital. The rating was initiated by Macquarie Research on Tuesday, April 5 with “Outperform”. The firm has “Sector Perform” rating given on Thursday, January 26 by RBC Capital Markets. The rating was maintained by Morgan Stanley on Wednesday, September 27 with “Equal-Weight”. The firm earned “Hold” rating on Monday, October 24 by Drexel Hamilton.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>